S100A8 and invasive carcinoma: In our study, in terms of frequency of positive cases, S100A8+ TCs was found in 30.7% (54/176) of pre-invasive carcinomas and 33.4% (175/524) of invasive carcinomas without a statistical difference (data not shown).